Clinical Profi le and Predictors of Outcomes of Patients with Peripartum Cardiomyopathy: The Philippine Heart Center Experience
Tóm tắt
Peripartum cardiomyopathy is a rare form of dilated cardiomyopathy characterized by heart failure and left ventricular dysfunction associated with pregnancy. While clinical characteristics of these patients have been previously described in literature, there is limited data regarding the natural history and predictors of outcomes of these patients in Asia, most specifi cally in Filipino patients. Clinical and echocardiographic data of 39 patients diagnosed with peripartum cardiomyopathy were analyzed. Patients were followed up for the occurrence of death and major adverse events (MAE) and outcomes were correlated with patient variables. The mean age of the patients was 28.4 ± 6.9 and the mean ejection fraction (EF) was 27.8 ± 8.4%. Heart failure was the most common symptom (98%) while arrhythmia was the initial presentation in 5 patients (12.8%). 14 patients had recovery of ejection fraction in 6 months (39%) with a mean EF of 55.5 ± 6.3. 16 patients had an initial EF of <25% (41%) and only 2 patients in this subgroup experienced improvement in EF. 29 patients experienced death and/or MAEs (74.4%). Multivariate analysis showed that an EF of <25% (HR 12.0,p=0.019), recovery of LV function (HR 0.23,p=0.05) and improvement of EF in 6 months (HR 0.32,p=0.024) were signifi cant predictors of MAEs. Kaplan Meier curves showed that patients whose ejection fraction was <25% had a 50% incidence of MAEs in 1 year with an increasing trend. Patients whose EF recovered in 6 months experienced a 60% freedom from MAE for almost 6 years. Patients with an EF of <25% had a mortality rate of 50% in two years. Patients with an EF of >25% had a 90% likelihood of survival for 8 years with a higher trend of mortality for patients whose EF did not recover in 6 months. Peripartum cardiomyopathy is associated with signifi cant morbidity and mortality. The degree of left ventricular dysfunction on presentation as well as improvement of EF within 6 months were predictive for the occurrence of death and major adverse events. This study emphasizes the need for aggressive treatment as well as clinical and echocardiographic follow up early in the course of disease in order to improve outcomes.
Tài liệu tham khảo
Sliwa K., Hilfi ker-Kleiner D., Petrie M.C.; Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the heart failure association of European Society of Cardiology Working Group on Peripartum Cardiomypathy. Eur J Heart Fail. 12 2010:767-778.
Ntusi, B.M. Mayosi, Aetiology and risk factors of peripartum cardiomyopathy a systematic review Int J Cardiol, 131 (2009), pp. 168-179.
Samonte V. et al, Clinical and echocardiographic profi le and outcomes of peripartum cardiomyopathy: the Philippine General Hospital experience, Heart Asia 2013;5:245-249.
Lim CP, Sim DK, Peripartum Cardiomyopathy: experience in an Asian tertiary centre, Singapore Med J. 2013 Jan;54(1):24-7.
Sliwa K, Fett J, Elkayam U. Peripartum cardiomyopathy. Lancet 2006;368:687e93.
M. Habli, T. O’Brien, E. Nowack, S. Khoury, J.R. Barton, B. Sibai, Peripartum cardiomyopathy: prognostic factors for long-term maternal outcome, Am J Obstet Gynecol, 199 (415.) (2008), pp. e1-5e.
Elkayam U, Akhter MW, Singh H, Khan S, Bitar F, Hameed A, Shotan A: Pregnancy associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation 2005, 111:2050-2055.
Gentry MB, Dias JK, Luis A, Patel R, Thornton J, Reed GL. African-American women have a higher risk for developing peripartum cardiomyopathy. J Am Coll Cardiol. 2010;55(7):654-659.
Amos A., Jaber W.A., Russell S.D.; Improved outcomes in peripartum cardiomyopathy with contemporary. Am Heart J. 152 2006:509-513.
Hellgren M. Hemostasis during normal pregnancy and puerperium. Semin Thromb Hemost 2003;29:125-30.
Safirstein JG, Ro AS, Grandhi S, Wang L, Fett JD, Staniloae C. Predictors of left ventricular recovery in a cohort of peripartum cardiomyopathy patients recruited via the internet. Int J Cardiol 2010 Sep 20.
Goland S, et al, Evaluation of the Clinical Relevance of Baseline Left Ventricular Ejection Fraction as a Predictor of Recovery or Persistence of Severe Dysfunction in Women in the United States With Peripartum Cardiomyopathy, Journal of Cardiac Failure Volume 17, Issue 5, Pages 426–430, May 2011.
Pearson GD, Veille JC, Rahimtoola S, et al. Peripartum cardiomyopathy: National Heart, Lung and Blood Institute and Offi ce of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA 2000;283:1183-8.
McNamara D, Damp J, Elkayam U, et al. Myocardial recovery at six months in peripartum cardiomyopathy: results of the NHLBI Multicenter IPAC study. Circulation 2013;128:A12898.
Whitehead S.J., Berg C.J., Chang J.; Pregnancy-related mortality due to cardiomyopathy: United States, 1991–1997. Obstet Gynecol. 102 2003:1326-1331.
Goland S., Modi K., Bitar F.; Clinical profi le and predictors of complications in peripartum cardiomyopathy. J Card Fail. 15 2009:645-650.
Barbosa et al, Rest left ventricular function and contractile reserve by dobutamine stress echocardiography in peripartum cardiomyopathy, Rev Port Cardiol. 2012 Apr;31(4):287-93.
Pillarisetti J1, Kondur A2, Alani A2, Reddy M1, Reddy M3, Vacek J1 et al, Peripartum cardiomyopathy: predictors of recovery and current state of implantable cardioverterdefi brillator use. J Am Coll Cardiol. 2014 Jul 1;63 (25 Pt A):2831-9. doi:10.1016/j.jacc.2014.04.014. Epub 2014 May 7.
Fett JD, Sannon H, Thelisma E, Sprunger T, Suresh V. Recovery from severe heart failure following peripartum cardiomyopathy. Int J Gynaecol Obstet 2009;104(2):125-7.
Biteker M, Ilhan E, Biteker G, Duman D, Bozkurt B. Delayed recovery in peripartum cardiomyopathy: an indication for long-term follow-up and sustained therapy. Eur J Heart Fail 2012;14:895-901.
Elkayam U, Clinical Characteristics of Peripartum Cardiomyopathy in the United State Diagnosis, Prognosis, and Management, J Am Coll Cardiol. 2011;58(7):659-670. doi:10.1016/j.jacc.2011.03.047.